The hypothesis describing how excessive translation in FXS, which is typically triggered by stimulation of the mGluR or another Gq-coupled receptor (when FMRP is absent), leads to cognitive and behavioural manifestations and has provided multiple potential sites for targeted therapy (Table 1 and Table 2). The gene discussed is FMR1; the disease is fragile X syndrome.